How non-celiac gluten sensitivity is diagnosed: the Salerno criteria
Short answer
There is no specific diagnostic test for non-celiac gluten sensitivity (NCGS)1, 2. The Salerno experts’ criteria, written to help clinicians reach a diagnosis3, describe this sequence:
- Celiac disease and wheat allergy are excluded first, while the person is still eating gluten4.
- Baseline symptoms are recorded, then a verified gluten-free diet is followed for at least six weeks5, 6.
- A responder is someone who meets the response criteria for at least half of the observation time; the criteria include a drop of more than 30% in one to three main symptoms7.
- In people who respond, a blinded crossover challenge of gluten against placebo confirms the diagnosis, on a strictly gluten-free baseline of at least four weeks8, 9, 34.
Part of Celiac diagnosis, testing and gluten sensitivity, 25 guides

Key points
- No specific test exists for NCGS; Coeliac UK and the Gluten Intolerance Group say so, and a 2025 Lancet review calls it a diagnosis of exclusion1, 2, 10.
- The Salerno criteria exclude celiac disease and wheat allergy first, while the person is still eating gluten4.
- Step 1 needs at least six weeks of verified gluten-free diet; Step 2 is a blinded gluten challenge8, 9, with a 30% variation between gluten and placebo as the cut-off the authors call somewhat arbitrary6, 11.
- A 2025 Lancet review says current evidence suggests that fermentable carbohydrates and nocebo effects contribute considerably to symptoms in many cases12, and one trial found that fructans induced symptoms13.
Why is there no blood test for non-celiac gluten sensitivity?
The Salerno paper starts from that gap: with no NCGS biomarker, the procedure for confirming the diagnosis needed standardizing14. Coeliac UK says there are no specific diagnostic tests1, and the Gluten Intolerance Group (GIG) says the same2.
A 2025 review in The Lancet says a definitive diagnosis remains elusive because of the absence of biomarkers, overlap with disorders of gut-brain interaction, and methodological challenges in dietary evaluation15. Its authors call NCGS a diagnosis of exclusion until causes are identified and tests developed10.
The Salerno authors write that NCGS should not be an exclusion diagnosis only16, and that a “test of treatment” with the gluten-free diet can be used to diagnose it17.
What is being diagnosed: the Salerno paper describes NCGS as a syndrome of intestinal and extra-intestinal symptoms linked to eating gluten-containing food in people who have neither celiac disease nor wheat allergy18.
Coeliac UK adds that some researchers define NCGS simply as an improvement in symptoms on a gluten-free diet, while a definitive diagnosis is still challenging67.
Why are celiac disease and wheat allergy ruled out first?
Because NCGS is defined by their absence18. The Salerno criteria say suspected cases should first have a full clinical and laboratory evaluation to exclude celiac disease and wheat allergy, while still eating gluten4. The Celiac Disease Foundation describes the terms NCGS and NCWS as used when removing gluten resolves symptoms after testing negative for celiac disease and a wheat allergy19. GIG puts it the same way: rule out celiac disease, wheat allergy and other causes first20.
The celiac side
NIDDK says doctors most often use blood tests and small-intestine biopsies to diagnose or rule out celiac disease21. The 2023 American College of Gastroenterology guideline describes antibody detection as very helpful for initial screening and says an intestinal biopsy is required in most patients to confirm the diagnosis22, 23.
These tests are read on a gluten-containing diet. NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing, because it can affect the results24. Coeliac UK likewise does not recommend trying a gluten-free diet as a first option, because it could prevent a celiac test from giving an accurate result25.
The wheat allergy side
GIG describes wheat allergy as an immune reaction to any of the hundreds of proteins in wheat26, and says IgE food allergies such as wheat allergy are generally diagnosed through RAST testing and a double-blind placebo test with the allergen, usually completed by an allergist27. GIG also notes a person can have a wheat allergy and also have celiac disease or NCGS28.
Coeliac UK says that after a negative celiac test, with other causes of symptoms ruled out, a person might wish to discuss the possibility of NCGS with their healthcare team29.
What are the Salerno criteria, step by step?
The criteria come from the 3rd International Expert Meeting on Gluten Related Disorders, held in Salerno, Italy, on 6–7 October 2014, to reach a consensus on how an NCGS diagnosis should be confirmed30. The paper lays out two steps after the exclusions.
| Stage | What the criteria specify |
|---|---|
| Before Step 1 | A normal gluten-containing diet for at least six weeks, with symptoms assessed at weeks −2, −1 and 0 to set a baseline5. |
| Symptom scoring | The patient picks one to three main symptoms and scores them from 1 (mild) to 10 (severe)31. |
| Step 1: gluten-free diet | At least six weeks of verified gluten-free diet6. |
| Step 1: who counts as a responder | A response is a decrease of at least 30% of the baseline score. A responder meets the response criteria (more than 30% reduction of one to three main symptoms, or at least one symptom with no worsening of others) for at least 50% of the observation time7. |
| If there is no response | The diagnosis of NCGS is excluded in people who show no symptomatic improvement after six weeks32. The paper says they should be investigated for other causes, such as FODMAP intolerance or small bowel bacterial overgrowth33. |
| Step 2: before the challenge | Step 2 is required to confirm the diagnosis in people who respond to the diet8. The baseline diet must be strictly gluten-free, to the level of a celiac diet, for at least four weeks34, with a dietitian assessing the diet35. |
| Step 2: the challenge | A double-blind placebo-controlled challenge at 8 g of gluten a day: one week of challenge, a one-week gluten-free washout, then a crossover to the second week9. |
| Reading the result | A variation of at least 30% between the gluten and the placebo challenge separates a positive from a negative result11. |
The authors say the 30% threshold is somewhat arbitrary and needs scientific validation11. They also call the protocol cumbersome, and not suited to large studies of how common NCGS is, because no validated biomarker exists36.
The full two-step evaluation can only be started in someone eating a normal gluten-containing diet37. The paper acknowledges that many patients are already on a gluten-free diet when first seen, and says a shortened procedure with only Step 2 may be adopted for them38.
What does a blinded gluten challenge look like?
The Salerno paper specifies the design in some detail:
- Design: a one-week challenge, a one-week washout on a strict gluten-free diet, then a crossover to the other arm9.
- Dose: 8 g of gluten a day9.
- The food it comes in: cooked, homogeneously distributed gluten39, free of FODMAPs40; the paper discourages gelatin capsules41.
- The placebo: it must be undistinguishable from the gluten preparation in look, texture and taste, and balanced in fibre, carbohydrate, fat and possibly protein42.
- Blinding: a single-blinded procedure could be sufficient in clinical practice, while a double-blind challenge remains the first choice for research43.
- Repeats: challenges may need to be repeated to offset the strong nocebo effect often seen in these patients44.
If a challenge is negative, the paper says the person should be investigated for other causes of IBS-like symptoms, such as FODMAP intolerance or small bowel bacterial overgrowth45.
What have research challenges shown, including nocebo responses?
Several trials and one pooled analysis have tested gluten challenges in people who report gluten sensitivity. Their results do not line up neatly:
| Study | Design | Reported result |
|---|---|---|
| Biesiekierski et al., Gastroenterology, 2013 | Double-blind cross-over trial of 37 people with NCGS and irritable bowel syndrome, but not celiac disease46. | Gluten-specific effects were observed in only 8% of participants47; the authors found no evidence of specific or dose-dependent effects of gluten in people with NCGS on low-FODMAP diets48. |
| Skodje et al., Gastroenterology, 2018 | Double-blind crossover challenge of 59 people on a self-instituted gluten-free diet, celiac disease excluded49; gluten (5.7 g), fructans (2.1 g) or placebo in muesli bars for 7 days50. | No difference in symptom scores between gluten and placebo51; fructans induced symptoms13. |
| de Graaf et al., Lancet Gastroenterology & Hepatology, 2024 | Randomised, double-blind, placebo-controlled trial with four groups, combining what participants expected to eat (gluten or gluten-free oat bread) with what they actually ate52. | The combination of expecting and eating gluten had the largest effect on gastrointestinal symptoms, which the authors read as a nocebo effect, though an additional effect of gluten cannot be ruled out53. |
| Lionetti et al., Frontiers in Physiology, 2017 | Systematic review and meta-analysis of eleven re-challenge studies54. | Pooled relapse after a gluten challenge was 30%, ranging between 7 and 77%55. |
The Lionetti review reports considerable heterogeneity in sample size, type and amount of gluten, challenge duration and placebo56. Its overall conclusion is that relapse after a gluten or a placebo challenge was similar, but that more patients are correctly classified when the Salerno criteria are applied57. For challenges run to those criteria, relapse was higher after gluten than after placebo (40 versus 24%)58.
The 2025 Lancet review adds that about 10% of adults worldwide self-report gluten or wheat sensitivity, while meta-analyses suggest 16–30% of them have symptoms specifically triggered by gluten in controlled challenges59. It says fermentable carbohydrates in challenge preparations limit interpretation60, and that current evidence suggests fermentable carbohydrates and nocebo effects contribute considerably to symptoms in many cases12.
Where do fructans and FODMAPs fit?
Several sources raise the possibility that something other than gluten is involved. The Salerno paper says the offending protein has not been identified and could include components other than gluten, such as amylase-trypsin inhibitors (ATIs)61. The Celiac Disease Foundation lists ATIs and fructans as other potential culprits62. Coeliac UK notes the debate over whether gluten or other components cause the sensitivity63.
The criteria say the challenge food should be free of FODMAPs40, and that people who do not respond to the diet33 or have a negative challenge45 should be investigated for other causes, including FODMAP intolerance. GIG also advises checking for intolerances to other substances in gluten-containing foods, such as FODMAPs or fructans64.
GIG says no laboratory test shows FODMAP intolerance; a FODMAP elimination diet is used instead65, and it says this should be done under the guidance of a Registered Dietitian or another healthcare professional66.
Questions people ask
Is there a blood test for non-celiac gluten sensitivity?
No. Coeliac UK and GIG each say there is no specific diagnostic test1, 2.
Does a negative celiac test mean I have NCGS?
Not by itself. The Salerno criteria say NCGS “should be considered” in patients with persistent complaints, normal celiac and wheat allergy serological markers on a gluten-containing diet, and usually worsening of symptoms after eating gluten-rich food68. Confirmation needs Step 28.
Is non-celiac gluten sensitivity the same as non-celiac wheat sensitivity?
The terms are used to refer to the same condition by the Celiac Disease Foundation19. The Salerno authors wrote that the terminology “NCGS” could be changed into “Non Celiac Wheat Sensitivity” in the near future, although this would exclude barley and rye69.
How long does the Salerno protocol take?
The paper specifies a six-week gluten-containing baseline5, at least six weeks of verified gluten-free diet in Step 16, at least four weeks of strict gluten-free baseline before the challenge34, then a one-week challenge, a one-week washout and a second one-week challenge9.
More in Celiac diagnosis, testing and gluten sensitivity
Can non-celiac gluten sensitivity go away? What the trials show and do not showWhat the sources say about whether non-celiac gluten sensitivity fades, what challenge and FODMAP trials found, and what to ask a clinician.
How celiac disease is diagnosed, step by stepFrom blood test to biopsy or no-biopsy diagnosis: what US, European and UK guidelines say, where they differ, and what they say about eating gluten first.
Celiac disease vs gluten intolerance: three conditions, three diagnosesHow celiac disease, non-celiac gluten sensitivity and wheat allergy differ in mechanism, diagnosis and diet, with a source behind every point.
At-home celiac and gluten sensitivity tests: what they can and cannot showWhat home celiac antibody kits, IgG food panels, stool and genetic tests can and cannot show, and what a result still needs from a clinician.
How a gluten challenge works before celiac testingWhat named celiac sources say about the amount and length of a gluten challenge before testing, side by side, and why a clinician plans it.
Bloated after bread or pasta? Why the celiac blood test comes before cutting glutenWhy bloating after bread or pasta cannot name its cause, why celiac blood tests come before a gluten-free diet, and what to ask a clinician.
All 25 guides in Celiac diagnosis, testing and gluten sensitivity
Related guides
Gluten-free and low FODMAP: what to check when symptoms continueHow gluten and FODMAPs differ, what guidelines list for persistent symptoms on a gluten-free diet, and FODMAP ingredients to look for on labels.
Cross-contact with non-celiac gluten sensitivity: what the research supports and what is unknownWhat FDA's gluten-free rule, the celiac and NCGS trials and the Salerno criteria say about trace gluten, and what is still unknown for NCGS.
What gluten does in the gut: celiac disease, wheat allergy and gluten sensitivity comparedHow celiac disease, wheat allergy and non-celiac gluten sensitivity differ in the gut, and why testing comes before cutting out gluten.
What happens when you stop eating gluten, condition by conditionWhat a gluten-free diet does in celiac disease, dermatitis herpetiformis, wheat allergy, gluten sensitivity and with no diagnosis, with the trials.
Sources
- [1, 25, 29, 63, 67] Coeliac UK, Gluten sensitivity (What is Non Coeliac Gluten Sensitivity?), checked Nov 17, 2026.
- [2, 64] Gluten Intolerance Group, What is non-celiac gluten sensitivity or NCGS? Is it same thing as gluten intolerance?, checked Nov 17, 2026.
- [3, 4, 5, 6, 7, 8, 9, 11, 14, 16, 17, 18, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 61, 68, 69] US National Library of Medicine (PubMed Central), Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria (Catassi et al., Nutrients, 2015), checked Nov 17, 2026.
- [10, 12, 15, 59, 60] PubMed (US National Library of Medicine), Non-coeliac gluten sensitivity (Biesiekierski et al., The Lancet, 2025), abstract, checked Nov 17, 2026.
- [13, 49, 50, 51] PubMed (US National Library of Medicine), Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity (Skodje et al., Gastroenterology, 2018), abstract, checked Nov 17, 2026.
- [19, 62] Celiac Disease Foundation, Non-Celiac Gluten/Wheat Sensitivity, checked Nov 17, 2026.
- [20, 26, 27, 28] Gluten Intolerance Group, Celiac Disease, Non-Celiac Gluten Sensitivity or Wheat Allergy: What is the Difference?, checked Nov 17, 2026.
- [21, 24] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Diagnosis of Celiac Disease, checked Nov 17, 2026.
- [22, 23] PubMed (US National Library of Medicine), American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (Rubio-Tapia et al., 2023), abstract, checked Nov 17, 2026.
- [46, 47, 48] PubMed (US National Library of Medicine), No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates (Biesiekierski et al., Gastroenterology, 2013), abstract, checked Nov 17, 2026.
- [52, 53] PubMed (US National Library of Medicine), The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity (de Graaf et al., Lancet Gastroenterology & Hepatology, 2024), abstract, checked Nov 17, 2026.
- [54, 55, 56, 57, 58] PubMed (US National Library of Medicine), Re-challenge Studies in Non-celiac Gluten Sensitivity: A Systematic Review and Meta-Analysis (Lionetti et al., Frontiers in Physiology, 2017), abstract, checked Nov 17, 2026.
- [65, 66] Gluten Intolerance Group, Low FODMAP Diet for Non-Celiac Gluten/Wheat Sensitivity, checked Nov 17, 2026.